At $2.70 pps, that's a market cap of less than $100M for APRI. We're significantly less than that today (about $85M m.cap).
Everyone is trying to tie a higher price for APRI to a launch of Vitaros, but there are all sorts of biotech stocks out there that are a few years away from a launch of anything, even a final approval for their drugs, and yet these "darling" biotechs enjoy marketcaps much higher, double, triple, quintuple or higher than APRI.
Even short of a launch, it may only be some serendipitous thing like one or more hedge funds deciding to get a significant position in APRI and this pps and marketcap would start rising without any news.
Don't get me wrong, i'm salivating for an actual launch of V somewhere; i happen to think, based on what Eicoman has presented, that it's gonna happen sooner than later.
Market Data 
Markets 
AI
